ArticleJournal of gastrointestinal oncology2024

Regorafenib for patients with progression of advanced hepatocellular carcinoma after treatment with atezolizumab plus bevacizumab: a case series.

Wendi Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.